AstraZeneca PLC
Market Cap
$222.76B
P/E Ratio
29.31
EPS
$4.90
Dividend Yield
1.57%
52-Week Range
$9573.50 — $15732.00
Volume
2.08M
Avg Volume
2.75M
Beta
0.23
P/E (TTM)
29.31
Forward P/E
1413.44
PEG Ratio
3.29
P/S (TTM)
5.24
P/B (TTM)
6.41
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
0.23%
ROA (TTM)
0.09%
ROIC
—
Gross Margin
0.78%
Operating Margin
0.23%
Net Margin
—
Debt/Equity
0.61
Current Ratio
0.94
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
+9.12%
EPS Growth (5Y)
+5.58%
Sales Growth (3Y)
+0.13%
Sales Growth (5Y)
+0.17%
EPS Est (This Year)
$10.16
EPS Est (Next Year)
$11.42
Dividend Yield
—
Annual Dividend
$76.70
Payout Ratio
—
Frequency
—
Ex-Dividend Date
2025-08-07
Cash/Share
$3.70
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
1.55B
Float
1.54B
Free Float %
99.57%
RSI (14)
62.80
SMA 20
$14914.10
SMA 50
$14248.20
SMA 200
$12516.24
ATR (14)
325.23
Volatility (Week)
0.02%
Volatility (Month)
0.02%
Pattern
—
1 Day
-2.10%
1 Week
-2.57%
1 Month
+6.35%
3 Months
+7.92%
6 Months
+22.29%
1 Year
—
YTD
+9.86%
All-Time High
$15474.36
Sector
Healthcare
Industry
Drug Manufacturers - General
Country
GB
Exchange
LSE
IPO Date
1993-05-21
Employees
94300
CEO
Pascal Claude Roland Soriot
Index Membership
—
Website
https://www.astrazeneca.com
AstraZeneca PLC (AZN.L) is a healthcare company in the drug manufacturers - general industry listed on the LSE. With a market capitalization of $222.76B, a P/E ratio of 29.31, and a dividend yield of 1.57%, AZN.L is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare AZN.L against other stocks using dozens of fundamental and technical filters.
AstraZeneca PLC (AZN.L) has a trailing twelve-month (TTM) P/E ratio of 29.31. This is near the market average range. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, AstraZeneca PLC (AZN.L) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
AstraZeneca PLC (AZN.L) has a market capitalization of $222.76 billion, classifying it as a mega-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.
AstraZeneca PLC (AZN.L) has returned +9.86% year-to-date. Past performance does not guarantee future results, but these figures reflect the stock's recent price trajectory relative to the broader market.